Treatment with UA induces mitophagy in microglia to bolster phagocytosis in amyloid-ß and tau pathology, decreasing cognitive decline in Alzheimer’s disease animal models [42]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.